share_log

华东医药:磺达肝癸钠注射液获美国FDA批准

JRJ Finance ·  Aug 27 15:56

华东医药公告,全资子公司中美华东申报的磺达肝癸钠注射液新药简略申请已获得美国FDA批准。磺达肝癸钠注射液为第三代肝素类抗血栓药物,具有明显优势,能预防深静脉血栓形成和急性肺栓塞。

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment